Exelixis Inc (FRA:EX9)
€ 32.75 -0.25 (-0.76%) Market Cap: 9.53 Bil Enterprise Value: 8.45 Bil PE Ratio: 21.93 PB Ratio: 4.30 GF Score: 81/100

Q1 2022 Exelixis Inc Earnings Call Transcript

May 10, 2022 / 09:00PM GMT
Release Date Price: €18.67 (+0.44%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Exelixis Q1 2022 Financial Results Conference Call. (Operator Instructions) Please be advised that conference is being recorded. (Operator Instructions) I would now like to hand the conference over to your speaker, Ms. Susan Hubbard, Executive Vice President of Public Affairs and Investor Relations. Please go ahead.

Susan T. Hubbard
Exelixis, Inc. - EVP of Public Affairs & IR

Thank you, Shari, and thank you all for joining us for the Exelixis First Quarter 2022 Financial Results Conference Call. Joining me on today's call are Mike Morrissey, our President and CEO; Chris Senner, our Chief Financial Officer; P.J. Haley, our Executive Vice President of Commercial; Vicki Goodman, our Chief Medical Officer; and Peter Lamb, our Chief Scientific Officer, who will together review our progress for the first quarter 2022 ended March 31, 2022. During the call today, we will refer to financial measures not calculated according to generally accepted accounting principles. Please refer to today's press

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot